Replies to post #180589 on Biotech Values

[DewDiligence]

TGTX adds an independent director, but 4/7 of the BoD (and hence the entire company) is still controlled by Opus Point Partners:

http://www.sec.gov/Archives/edgar/data/1001316/000114420414074509/v396873_ex99-1.htm